00_MJ_Intro_Budapest16.pptx

830 / 1173

Retreatment: Summary
0 20 40 60 80 100 120
kidney
Initial dose
[% of tolerance-EQD2]
Reirradiation dose
[% of tolerance-EQD2]0
20
40
60
80
100
120
skin/oral mucosa
early effects
late effects
Initial dose
[% of tolerance-BED]
0 20 40 60 80 100
lung
(pneumonitis)
0
20
40
60
80
100
120
spinal cord
Reirradiation dose
[% of tolerance-EQD2]
Initial dose
[% of tolerance-EQD2]
0 20 40 60 80 100